For instance, retrospective analysis of an initial study involving subjects with MDD treated with selective serotonin reuptake inhibitors (SSRIs) or venlafaxine demonstrated that ATR predicted response with an accuracy of 70%, with 82% sensitivity and 54% specificity (Iosifescu et al., 2009). This evidence concerns the gene ATR and major depressive disorder.